Calcium Dibutyryladenosine Cyclophosphate

二丁酰环磷腺苷钙

Report date: 2022/12/07 18:09:27

Base Information

Drug NameCalcium Dibutyryladenosine Cyclophosphate
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsPsoriasisShock, CardiogenicMyocardial Infarction +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsPsoriasisShock, CardiogenicMyocardial Infarction +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A